NASDAQ:ACOR - Acorda Therapeutics News Headlines

$7.53
-0.07 (-0.92 %)
(As of 06/16/2019 11:07 AM ET)
Today's Range
$7.48
Now: $7.53
$7.89
50-Day Range
$7.16
MA: $10.13
$11.89
52-Week Range
$6.96
Now: $7.53
$31.55
Volume820,616 shs
Average Volume911,812 shs
Market Capitalization$362.42 million
P/E Ratio4.14
Dividend YieldN/A
Beta1.37

Headlines

Acorda Therapeutics (NASDAQ ACOR) News Headlines

Source:
DateHeadline
Dr. Reddy's Inks Deal to Sell Neurology Branded ProductsDr. Reddy's Inks Deal to Sell Neurology Branded Products
finance.yahoo.com - June 14 at 6:29 PM
Critical Analysis: Acorda Therapeutics (NASDAQ:ACOR) versus Avrobio (NASDAQ:AVRO)Critical Analysis: Acorda Therapeutics (NASDAQ:ACOR) versus Avrobio (NASDAQ:AVRO)
www.americanbankingnews.com - June 14 at 12:15 PM
Acorda Therapeutics Enters Oversold TerritoryAcorda Therapeutics Enters Oversold Territory
www.nasdaq.com - June 13 at 7:13 PM
Catalyst Pharma Files Lawsuit Against FDA Approval of RuzurgiCatalyst Pharma Files Lawsuit Against FDA Approval of Ruzurgi
finance.yahoo.com - June 13 at 7:13 PM
Denalis Hunter Syndrome Candidate Gets Orphan Drug StatusDenali's Hunter Syndrome Candidate Gets Orphan Drug Status
www.msn.com - June 12 at 11:46 AM
Acorda Therapeutics Inc (ACOR) Given Average Rating of "Hold" by AnalystsAcorda Therapeutics Inc (ACOR) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - June 5 at 10:13 AM
Celldex Presents Data From CDX-3379 Study at ASCO, Stock DownCelldex Presents Data From CDX-3379 Study at ASCO, Stock Down
www.msn.com - June 4 at 6:16 PM
Seattle Genetics, Astellas' Cancer Candidate Attains 44% ORRSeattle Genetics, Astellas' Cancer Candidate Attains 44% ORR
finance.yahoo.com - June 4 at 6:16 PM
Theravance Biopharma Appoints Andrew Hindman as Senior Vice President and Chief Financial OfficerTheravance Biopharma Appoints Andrew Hindman as Senior Vice President and Chief Financial Officer
www.marketwatch.com - June 4 at 9:06 AM
Acorda Therapeutics Debuts Art Exhibition Inspired by People with Parkinson’s at the 5th World Parkinson CongressAcorda Therapeutics Debuts Art Exhibition Inspired by People with Parkinson’s at the 5th World Parkinson Congress
finance.yahoo.com - June 3 at 8:58 AM
Acorda (ACOR) Down 11.3% Since Last Earnings Report: Can It Rebound?Acorda (ACOR) Down 11.3% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - June 1 at 5:10 PM
Mesoblast Starts Rolling BLA Submission for Remestemcel-LMesoblast Starts Rolling BLA Submission for Remestemcel-L
finance.yahoo.com - May 30 at 6:08 PM
Fate Therapeutics (FATE) Surges: Stock Moves 6.8% HigherFate Therapeutics (FATE) Surges: Stock Moves 6.8% Higher
finance.yahoo.com - May 29 at 6:27 PM
Acorda Therapeutics Inc (ACOR) Expected to Announce Quarterly Sales of $25.23 MillionAcorda Therapeutics Inc (ACOR) Expected to Announce Quarterly Sales of $25.23 Million
www.americanbankingnews.com - May 28 at 1:26 AM
Zacks: Brokerages Expect Acorda Therapeutics Inc (ACOR) Will Post Earnings of -$1.02 Per ShareZacks: Brokerages Expect Acorda Therapeutics Inc (ACOR) Will Post Earnings of -$1.02 Per Share
www.americanbankingnews.com - May 26 at 10:13 PM
Acorda Therapeutics to Present at Jefferies 2019 Healthcare ConferenceAcorda Therapeutics to Present at Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 23 at 9:05 AM
Acorda Therapeutics (ACOR) Research Coverage Started at WedbushAcorda Therapeutics (ACOR) Research Coverage Started at Wedbush
www.americanbankingnews.com - May 22 at 6:22 PM
Acorda Therapeutics (ACOR) Q1 2019 Earnings Call TranscriptAcorda Therapeutics (ACOR) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 4 at 5:12 PM
Edited Transcript of ACOR earnings conference call or presentation 2-May-19 12:30pm GMTEdited Transcript of ACOR earnings conference call or presentation 2-May-19 12:30pm GMT
finance.yahoo.com - May 3 at 9:09 AM
Parkinsons Disease Drugs And Therapeutics Market Size, key Manufacturers, Application, Type, End-user, Forecast to 2028Parkinsons Disease Drugs And Therapeutics Market Size, key Manufacturers, Application, Type, End-user, Forecast to 2028
www.marketwatch.com - May 2 at 9:07 AM
Acorda Q4 Ampyra sales down 60% on generic encroachmentAcorda Q4 Ampyra sales down 60% on generic encroachment
seekingalpha.com - May 2 at 9:07 AM
Acorda Therapeutics (ACOR) Reports Q1 Loss, Tops Revenue EstimatesAcorda Therapeutics (ACOR) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 2 at 9:07 AM
Acorda Therapeutics Q1 2019 Earnings PreviewAcorda Therapeutics Q1 2019 Earnings Preview
seekingalpha.com - May 1 at 6:55 PM
Earnings Preview: Acorda Therapeutics (ACOR) Q1 Earnings Expected to DeclineEarnings Preview: Acorda Therapeutics (ACOR) Q1 Earnings Expected to Decline
finance.yahoo.com - April 25 at 6:37 PM
Should You Be Concerned About Acorda Therapeutics, Inc.'s (NASDAQ:ACOR) Historical Volatility?Should You Be Concerned About Acorda Therapeutics, Inc.'s (NASDAQ:ACOR) Historical Volatility?
finance.yahoo.com - April 22 at 5:45 PM
Acorda First Quarter 2019 Update: Webcast/Conference Call Scheduled for May 2, 2019Acorda First Quarter 2019 Update: Webcast/Conference Call Scheduled for May 2, 2019
finance.yahoo.com - April 18 at 6:55 PM
A startup just raised $27 million to make a new kind of painkiller using technology from Harvard scientists, as the race to replace opioids heats upA startup just raised $27 million to make a new kind of painkiller using technology from Harvard scientists, as the race to replace opioids heats up
www.businessinsider.com - April 17 at 6:46 PM
Acorda Therapeutics (ACOR) to Present New Long-Term Data for INBRIJA at AMCP - StreetInsider.comAcorda Therapeutics (ACOR) to Present New Long-Term Data for INBRIJA at AMCP - StreetInsider.com
www.streetinsider.com - March 19 at 6:59 PM
Acorda to Present New Long-Term Data for INBRIJA™ (levodopa inhalation powder) at Academy of Managed Care Pharmacy Annual MeetingAcorda to Present New Long-Term Data for INBRIJA™ (levodopa inhalation powder) at Academy of Managed Care Pharmacy Annual Meeting
finance.yahoo.com - March 19 at 9:22 AM
Acorda Therapeutics, Inc. (ACOR) After Hours TradingAcorda Therapeutics, Inc. (ACOR) After Hours Trading
www.nasdaq.com - March 18 at 7:08 PM
Acorda Therapeutics IncAcorda Therapeutics Inc
www.bloomberg.com - March 18 at 7:08 PM
Acorda (ACOR) Down 6% Since Last Earnings Report: Can It Rebound?Acorda (ACOR) Down 6% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - March 16 at 6:17 PM
Should You Be Concerned About Acorda Therapeutics, Inc.’s (NASDAQ:ACOR) ROE?Should You Be Concerned About Acorda Therapeutics, Inc.’s (NASDAQ:ACOR) ROE?
finance.yahoo.com - March 15 at 6:53 PM
Acorda Therapeutics (ACOR) Gains But Lags Market: What You Should KnowAcorda Therapeutics (ACOR) Gains But Lags Market: What You Should Know
finance.yahoo.com - March 15 at 6:53 PM
Acorda Therapeutics chief business officer bids adieuAcorda Therapeutics chief business officer bids adieu
seekingalpha.com - March 8 at 9:12 AM
Acorda Therapeutics Announces Management ChangesAcorda Therapeutics Announces Management Changes
finance.yahoo.com - March 8 at 9:12 AM
Acorda to Present at Oppenheimers 29th Annual Healthcare Conference - Business WireAcorda to Present at Oppenheimer's 29th Annual Healthcare Conference - Business Wire
www.businesswire.com - March 7 at 6:19 PM
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Acorda Therapeutics, Inc. Investors (ACOR) - GlobeNewswireGlancy Prongay & Murray LLP Announces Investigation on Behalf of Acorda Therapeutics, Inc. Investors (ACOR) - GlobeNewswire
globenewswire.com - March 6 at 9:13 AM
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Acorda Therapeutics, Inc. Investors (ACOR)Glancy Prongay & Murray LLP Announces Investigation on Behalf of Acorda Therapeutics, Inc. Investors (ACOR)
finance.yahoo.com - March 6 at 9:13 AM
Acorda to Present at Oppenheimer’s 29th Annual Healthcare ConferenceAcorda to Present at Oppenheimer’s 29th Annual Healthcare Conference
finance.yahoo.com - March 6 at 9:13 AM
Acorda launches Inbrija in U.S.Acorda launches Inbrija in U.S.
seekingalpha.com - February 28 at 6:30 PM
Acorda Therapeutics Announces Commercial Launch of INBRIJA™ (levodopa inhalation powder)Acorda Therapeutics Announces Commercial Launch of INBRIJA™ (levodopa inhalation powder)
finance.yahoo.com - February 28 at 6:30 PM
Acorda Therapeutics to Present at Cowen Annual Health Care Conference - Business WireAcorda Therapeutics to Present at Cowen Annual Health Care Conference - Business Wire
www.businesswire.com - February 26 at 6:09 PM
Parkinsons Disease Drugs And Therapeutics Market 2019 Global Analysis, Opportunities and Forecast to 2028Parkinsons Disease Drugs And Therapeutics Market 2019 Global Analysis, Opportunities and Forecast to 2028
www.marketwatch.com - February 26 at 9:20 AM
Acorda Therapeutics to Present at Cowen Annual Health Care ConferenceAcorda Therapeutics to Present at Cowen Annual Health Care Conference
finance.yahoo.com - February 26 at 9:20 AM
Acorda Therapeutics Becomes OversoldAcorda Therapeutics Becomes Oversold
www.nasdaq.com - February 20 at 6:18 PM
Acorda Therapeutics to Present at Leerink Global Healthcare ConferenceAcorda Therapeutics to Present at Leerink Global Healthcare Conference
finance.yahoo.com - February 19 at 9:17 AM
Edited Transcript of ACOR earnings conference call or presentation 14-Feb-19 9:30pm GMTEdited Transcript of ACOR earnings conference call or presentation 14-Feb-19 9:30pm GMT
finance.yahoo.com - February 18 at 5:35 PM
Acorda (ACOR) Q4 Earnings and Revenues Surpass Estimates - NasdaqAcorda (ACOR) Q4 Earnings and Revenues Surpass Estimates - Nasdaq
www.nasdaq.com - February 16 at 8:55 AM
Acorda Therapeutics, Inc. 2019 Q4 - Results - Earnings Call Slides - Seeking AlphaAcorda Therapeutics, Inc. 2019 Q4 - Results - Earnings Call Slides - Seeking Alpha
seekingalpha.com - February 16 at 8:55 AM
This page was last updated on 6/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel